ReachMD
Be part of the knowledge.™Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?
Physiogenomics and Diabetes
Share this program on:
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
Overview
Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.
Presenters
Recommended
Details
Presenters
Comments
Recommended
Overview
Is the risk of the glitazones worth the benefit? What if you could predict which patients were susceptible? Dr. Ruaño discusses with host Dr. Leslie Lundt how diabetes patients may benefit from the rapidly growing field of physiogenomics.
Presenters
Facebook Comments